Helix BioPharma Corp.: Helix Biopharma Corp. Closes Private

RICHMOND HILL, ON / ACCESSWIRE / April 21, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology

Related Keywords

Canada , Richmond Hill , Ontario , Canadian , Frank Michalargias , Helix Biopharma Corp , Helix Biopharma , Jerzy Wilczewski , Multilateral Instrument , Minority Security Holders , Special Transactions , Chief Financial Officer , Looking Statements , Annual Information Form , Helix , Iopharma , Orp , Loses , Private , Placement ,